Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease

por Mayor, R, Casadomé, L, Azuara, D, Moreno, V, Clark, S J, Capellà, G, Peinado, M A
Publicado 2009

Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer

por Grasselli, J, Elez, E, Caratù, G, Matito, J, Santos, C, Macarulla, T, Vidal, J, Garcia, M, Viéitez, J M, Paéz, D, Falcó, E, Lopez Lopez, C, Aranda, E, Jones, F, Sikri, V, Nuciforo, P, Fasani, R, Tabernero, J, Montagut, C, Azuara, D, Dienstmann, R, Salazar, R, Vivancos, A
Publicado 2017